⁤Roberto Caricchio has been studying lupus for nearly three decades, observing slow progress in treatment. ⁤⁤However, German scientists recently discovered that cellular medicines can drive lupus into remission, something that has been unable to be achieved with traditional drugs. ⁤⁤This breakthrough has sparked a surge in clinical trials and industry interest. ⁤⁤Presented at the European Alliance of Associations for Rheumatology’s annual meeting, this study has promising results for treating lupus and other autoimmune diseases with CAR-T therapy. ⁤⁤Companies including Kyverna Therapeutics, Cabaletta Bio, and Novartis shared updates on their clinical studies, indicating positive responses in many patients. ⁤⁤Despite these advances, the complexity and cost of manufacturing CAR-T therapies and their potential long-term side effects remain a consistent challenge. ⁤⁤Experts believe these treatments hold great promise but emphasize the need for further research and testing to ensure efficacy and safety for all patients. ⁤⁤The future of autoimmune disease treatment looks promising, with cellular therapy leading the way. ⁤

To read more, click here. 

[Source: BioPharma, June 17th 2024.]